Actuarial probability curves of disease-free survival for patients with secondary AML who received induction chemotherapy before transplantation and were in first or second complete remission or first untreated relapse at time of transplantation (n = 20) compared to patients with secondary AML who received no induction chemotherapy before transplantation (n = 46). Tick marks represent patients alive in continuous complete remission.